The other morning on CNBC a guest mentioned a publicly traded NASDAQ stock and got chided by the moderartor who said " we are not allowed to talk about sub $1billion in market cap. I would imagine that also aplies to OTC stocks, which makes me want to speculate if CYDY is even mentioned on mainstream media when they crush the Brazil trials and ANVISA ( or FDA maybe) reccomends to halt the trial for positive efficacy .
Look at EDSA, little company , halted for efficacy, stock runs up 1 day and they are back in the dust again. No mention at all